# ESOMEPRAZOLE MAGNESIUM
> **ANDA217022** · Abbreviated New Drug Application (Generic) · Sponsor: ZHEJIANG YONGTAI · Approved 2023-12-27
## Drug
- **FDA Application Number:** ANDA217022
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ESOMEPRAZOLE MAGNESIUM
- **Generic name:** ESOMEPRAZOLE MAGNESIUM
- **Active ingredients:** ESOMEPRAZOLE MAGNESIUM
- **Dosage form:** CAPSULE, DELAYED REL PELLETS
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ZHEJIANG YONGTAI
- **Manufacturer:** Zhejiang Yongtai Pharmaceutical Co., Ltd
- **First approval:** 2023-12-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217022)
---
*AI Analytics · CC0 1.0*